Firefly Luciferase – RPMI 8226 Recombinant Cell Line

Catalog #
79834
$2,045 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant RPMI 8226 cells stably expressing firefly (Photinus pyralis) luciferase. These cells naturally express human B-Cell Maturation Antigen (BCMA) and represent a relevant cell line-derived xenograft (CDX) model.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Product Info
Storage and Usage
Citations
Host Cell Line
RPMI 8226, human B cells isolated from a plasmacytoma/myeloma patient, suspension.
Supplied As
Each vial contains 2 x 106 cells in 1 ml of cell freezing medium (BPS Bioscience #79796)
Materials Required But Not Supplied
Name Ordering Information
Thaw Medium 10 BPS Bioscience #79704
Growth Medium 10A BPS Bioscience #79835
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

RPMI 8226 cells are human B cells isolated from a plasmacytoma/myeloma patient. RPMI 8226 cells constitutively express BCMA and offer a physiologically relevant platform to evaluate cancer-directed immunotherapies, such as Chimeric Antigen Receptor (CAR) T cells. The Firefly Luciferase RPMI 8226 Cell Line makes an excellent target to measure specific killing by CAR-T or NK cells targeting BCMA or other targets of interest.